{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T03:35:19Z","timestamp":1773632119289,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["2015-NG45001-00"],"award-info":[{"award-number":["2015-NG45001-00"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["2016-NG45003-00"],"award-info":[{"award-number":["2016-NG45003-00"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["2017-NG45003-00"],"award-info":[{"award-number":["2017-NG45003-00"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["4840-302-210-13"],"award-info":[{"award-number":["4840-302-210-13"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.bbrc.2018.12.146","type":"journal-article","created":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T08:52:35Z","timestamp":1546246355000},"page":"611-616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A therapeutic human antibody against the domain 4 of the Bacillus anthracis protective antigen shows protective efficacy in a mouse model"],"prefix":"10.1016","volume":"509","author":[{"given":"Bo-Eun","family":"Ahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Won","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hae-Ri","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun-Je","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ok-Kyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Ho","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jungchan","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gi-eun","family":"Rhie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.12.146_bib1","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1128\/MMBR.64.3.548-572.2000","article-title":"Resistance of Bacillus endospores to extreme terrestrial and extraterrestrial environments","volume":"64","author":"Nicholson","year":"2000","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.bbrc.2018.12.146_bib2","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2672.2005.02736.x","article-title":"Spores of Bacillus subtilis: their resistance to and killing by radiation, heat and chemicals","volume":"101","author":"Setlow","year":"2006","journal-title":"J.\u00a0Appl. Microbiol."},{"key":"10.1016\/j.bbrc.2018.12.146_bib3","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3390\/toxins3081004","article-title":"Monoclonal antibody therapies against anthrax","volume":"3","author":"Chen","year":"2011","journal-title":"Toxins"},{"key":"10.1016\/j.bbrc.2018.12.146_bib4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4161\/mabs.3.6.17621","article-title":"Antibodies for biodefense","volume":"3","author":"Froude","year":"2011","journal-title":"MAbs"},{"key":"10.1016\/j.bbrc.2018.12.146_bib5","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3389\/fmicb.2015.01320","article-title":"Approval of raxibacumab for the treatment of inhalation anthrax under the US Food and Drug administration \"animal rule","volume":"6","author":"Tsai","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbrc.2018.12.146_bib6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4161\/mabs.1.6.10195","article-title":"Raxibacumab","volume":"1","author":"Mazumdar","year":"2009","journal-title":"MAbs"},{"key":"10.1016\/j.bbrc.2018.12.146_bib7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1128\/IAI.73.2.795-802.2005","article-title":"A\u00a0high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge","volume":"73","author":"Mohamed","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbrc.2018.12.146_bib8","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s40265-016-0577-0","article-title":"Obiltoxaximab: first global approval","volume":"76","author":"Greig","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.bbrc.2018.12.146_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tim.2004.12.004","article-title":"Anthrax toxin: the long and winding road that leads to the kill","volume":"13","author":"Abrami","year":"2005","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.bbrc.2018.12.146_bib10","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.280.5364.734","article-title":"Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor","volume":"280","author":"Duesbery","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2018.12.146_bib11","doi-asserted-by":"crossref","first-page":"36334","DOI":"10.1074\/jbc.M004778200","article-title":"An extended conformation of calmodulin induces interactions between the structural domains of adenylyl cyclase from Bacillus anthracis to promote catalysis","volume":"275","author":"Drum","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2018.12.146_bib12","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1021\/bi000310u","article-title":"A\u00a0quantitative study of the interactions of Bacillus anthracis edema factor and lethal factor with activated protective antigen","volume":"39","author":"Elliott","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2018.12.146_bib13","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/385833a0","article-title":"Crystal structure of the anthrax toxin protective antigen","volume":"385","author":"Petosa","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2018.12.146_bib14","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1128\/JB.183.6.2111-2116.2001","article-title":"Involvement of domain 3 in oligomerization by the protective antigen moiety of anthrax toxin","volume":"183","author":"Mogridge","year":"2001","journal-title":"J.\u00a0Bacteriol."},{"key":"10.1016\/j.bbrc.2018.12.146_bib15","doi-asserted-by":"crossref","first-page":"30936","DOI":"10.1074\/jbc.M301154200","article-title":"Alanine-scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody","volume":"278","author":"Rosovitz","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2018.12.146_bib16","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.bmc.2007.11.001","article-title":"Selection and characterization of human antibodies neutralizing Bacillus anthracis toxin","volume":"16","author":"Zhou","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbrc.2018.12.146_bib17","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/CVI.00792-14","article-title":"Generation and characterization of human monoclonal antibodies targeting anthrax protective antigen following vaccination with a recombinant protective antigen vaccine","volume":"22","author":"Chi","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.bbrc.2018.12.146_bib18","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1365-2958.1990.tb00685.x","article-title":"Construction and characterization of a protective antigen-deficient Bacillus anthracis strain","volume":"4","author":"Cataldi","year":"1990","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bbrc.2018.12.146_bib19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.femsim.2005.05.008","article-title":"Expression and secretion of the protective antigen of Bacillus anthracis in Bacillus brevis","volume":"45","author":"Rhie","year":"2005","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.bbrc.2018.12.146_bib20","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1128\/IAI.01145-10","article-title":"The poly-gamma-D-glutamic acid capsule of Bacillus anthracis enhances lethal toxin activity","volume":"79","author":"Jang","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbrc.2018.12.146_bib21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12033-011-9398-2","article-title":"One-step detection of aflatoxin-B(1) using scFv-alkaline phosphatase-fusion selected from human phage display antibody library","volume":"49","author":"Rangnoi","year":"2011","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.bbrc.2018.12.146_bib22","series-title":"Cloning and Expressing Recombinant Protective Antigen Domains of B. Anthracis","author":"Sarkes","year":"2011"},{"key":"10.1016\/j.bbrc.2018.12.146_bib23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.phrp.2012.07.006","article-title":"Serological correlate of protection in Guinea pigs for a recombinant protective antigen anthrax vaccine produced from Bacillus brevis","volume":"3","author":"Chun","year":"2012","journal-title":"Osong Public Health Res Perspect"},{"key":"10.1016\/j.bbrc.2018.12.146_bib24","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/0264-410X(95)00139-R","article-title":"Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in Guinea pigs","volume":"13","author":"Ivins","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2018.12.146_bib25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A\u00a0Simple method of estimating fifty per cent endpoints12","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.bbrc.2018.12.146_bib26","doi-asserted-by":"crossref","first-page":"11346","DOI":"10.1073\/pnas.172229899","article-title":"Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody","volume":"99","author":"Nowakowski","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2018.12.146_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/hyb.1986.5.21","article-title":"Protection of mice against tetanus toxin by combination of two human monoclonal antibodies recognizing distinct epitopes on the toxin molecule","volume":"5","author":"Ziegler-Heitbrock","year":"1986","journal-title":"Hybridoma"},{"key":"10.1016\/j.bbrc.2018.12.146_bib28","doi-asserted-by":"crossref","first-page":"e0006133","DOI":"10.1371\/journal.pntd.0006133","article-title":"SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies","volume":"11","author":"Chao","year":"2017","journal-title":"PLoS Neglected Trop. Dis."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18328134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18328134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T16:33:20Z","timestamp":1755102800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X18328134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0006291X18328134"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.12.146","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A therapeutic human antibody against the domain 4 of the Bacillus anthracis protective antigen shows protective efficacy in a mouse model","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.12.146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}